PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune liver disease
暂无分享，去创建一个
T. Gevers | M. Londoño | K. Schulze | Constantin Schmidt | E. Tjwa | G. Buescher | J. Dumortier | Meunier | T. Fründt | Lucy | V. Joerg | J. Felden | I. Piseddu | B. T. Beretta-Piccoli | Lorenz Kocheise | F. Fianchi | Sutter | Joscha Vonderlin | F. Glaser | M. Riveiro‐Barciela | S. Huber | Marcial | P. Jan | A. Lohse | Pia Goeggelmann | Sona | Frankova | Thomas Roesner | Sebode | Ignazio Piseddu